https://www.globenewswire.com/news-release/2024/06/17/2899527/0/en/BioRestorative-Therapies-Regains-Compliance-with-Nasdaq-Listing-Rule-5250-c-1-Reports-First-Quarter-2024-Financial-Results.html
BioRestorative Therapies Regains Compliance with Nasdaq
- Significant YoY improvement in operating performance - - Ends Q1-2024 with $16.4 million cash, cash equivalents, and marketable securities - MELVILLE,...
therapiesregainscompliancenasdaq
https://www.nasdaq.com/market-activity/stocks/brtx/institutional-holdings
BioRestorative Therapies, Inc. Common Stock (NV) (BRTX) Institutional Holdings | Nasdaq
Find the latest institutional holdings data for BioRestorative Therapies, Inc. Common Stock (NV) (BRTX) including shareholders, ownership summaries, and...
common stockinstitutional holdingstherapiesincnv
https://www.sofi.com/invest/stock/BRTX/
Buy BioRestorative Therapies, Inc. - Common Stock Stock - BRTX Stock Price, Quote & News | SoFi
See real time price charts for BRTX stock, historical data, and recent news. Buy BRTX stock online with no commission fees.
common stockprice quotebuytherapiesinc
https://ir.biorestorative.com/
BioRestorative Therapies, Inc. (BRTX)
BioRestorative Therapies was founded by scientists and researchers committed to developing stem cell therapies to address unmet needs in patients with highly...
therapiesincbrtx
https://www.benzinga.com/insights/earnings/25/05/45387504/uncovering-potential-biorestorative-therapiess-earnings-preview
Uncovering Potential: BioRestorative Therapies's Earnings Preview - BioRestorative Therapies...
uncoveringpotentialtherapiesearningspreview